Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05698-2 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Yuhang Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Nature Science Foundation of China, the Shanghai East Hospital Clinical Research Project.
Abstract (Originalsprache)
Background
Ewing’s sarcoma (ES) is an aggressive cancer of bone and soft tissue, most of which tend to occur in the bone. Extraosseous Ewing’s sarcoma (EES) of the cervix is extremely rare. Case presentation In the present work, we reported a 39-year-old cervical EES patient with a 2.5*2.1*1.8 cm tumor mass. According to previous literatures, our case is the smallest tumor found in primary cervical ES ever. The patient initially came to our hospital due to vaginal bleeding, and then the gynecological examination found a neoplasm between the cervical canal and partially in the external cervical orifice. The diagnosis of EES was confirmed below: Hematoxylin & Eosin staining (H&E) revealed small round blue malignant cells in biopsy specimens. Immunohistochemistry (IHC) showed the positive staining for CD99, NKX2.2, and FLI1. Disruption of EWSR1 gene was found by fluorescence in situ hybridization (FISH), and the EWSR1–FLI1 gene fusion was determined by next-generation sequencing (NGS). The patient received laparoscopic wide hysterectomy, bilateral adnexectomy, pelvic lymphadenectomy, and postoperative adjuvant chemotherapy and remained disease free with regular follow-up for 1 year.
Conclusions
Through a systematic review of previously reported cervical ES and this case, we highlighted the importance of FISH and NGS for the accuracy of ESS diagnosis, which could assist on the optimal treatment strategy. However, due to the rarity of the disease, there is no standard treatment schemes. Investigation on molecular pathological diagnosis and standardization of treatment regimens for cervical ES are critical to patients’ prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, China.
- Department of Pathology, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, China. gaojinli.ok@163.com.
- Department of Gynecology, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, China. fang_li@tongji.edu.cn.
Förderung
- the National Nature Science Foundation of China
- the Shanghai East Hospital Clinical Research Project
Zitieren
APA
Xiao, Y., Zhi, Y., Cao, G., Ma, H., Gao, J., & Li, F. (2024). Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05698-2
Vancouver
Xiao Y, Zhi Y, Cao G, Ma H, Gao J, Li F. Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05698-2
BibTeX
@article{Xiao2024,
author = {Xiao, Yuhang and Zhi, Yong and Cao, Guangxu and Ma, Heling and Gao, Jinli and Li, Fang},
title = {Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05698-2}
}
EUVIMED